You are hereBiblio / Amanda's Absence
Amanda's Absence
| Title | Amanda's Absence |
| Publication Type | Case Study |
| Year of Publication | 2005 |
| Authors | Johnson, Dan |
| Corporate Authors | Wake Forest University, Biology Department |
| Date Published | 10/2005 |
| Publisher | National Center for Case Study Teaching in Science, University at Buffalo |
| Publication Language | eng |
| Keywords | Big Pharma , BIOETHICS , BIOLOGY , BUSINESS ethics , CHEMISTRY , Clinical , Drug , FDA , FOOD , MEDICINE , pharmaceutical; , Product and Consumer Safety , Risk-Benefit , Vioxx |
| Abstract | When chronic pain forces a top student to withdraw from college, biology instructor Dr. Sharpe learns that medications (in this case, Vioxx) may be removed from the market for many reasons, including safety concerns. As the case unfolds, students learn how the FDA balances drug safety against medical needs. As written, the case is appropriate for a non-majors biology course. It could also be adapted for use in a more advanced course in cell biology, pharmacology, or biochemistry, or modified to explore statistical analysis, specific analytical methods used for risk/benefit analysis, or bioethical issues. |
| Notes | Case from the National Center for Case Study Teaching in Science, University of Buffalo. http://sciencecases.lib.buffalo.edu/cs/ |
| URL | Click here for the document |
| Audience Level | Undergraduate |
| Abbreviated Case Name | Amanda's Absence |
